Shots:
The US FDA has approved the SetPoint System to treat adults with mod. to sev. rheumatoid arthritis (RA) who are inadequately managed by or intolerant to existing advanced therapies, incl. biologics & targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs)
Approval was based on RESET-RA study evaluating SetPoint System vs sham device in 242 pts, which…
